Association of loss of epithelial syndecan-1 with stage and local metastasis of colorectal adenocarcinomas: An immunohistochemical study of clinically annotated tumors

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Hashimoto, Yosuke ^a,c   Skacel, Marek ^a,d   Adams, Josephine C ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^c SHIZUOKA CANCER CENTER   (Japan)

^d Dahl Chase Pathology Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FASCIN; KI 67 ANTIGEN; SYNDECAN 1; ACTIN BINDING PROTEIN; CARRIER PROTEIN; SDC1 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGE; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CELL MEMBRANE; CELLULAR DISTRIBUTION; COLON MUCOSA; COLORECTAL CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; EPITHELIUM CELL; FEMALE; FOLLOW UP; GENE EXPRESSION; GENE LOSS; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; PROGNOSIS; SEX DIFFERENCE; TISSUE MICROARRAY; TUMOR CELL; TUMOR LOCALIZATION; UNITED STATES; UPREGULATION; ADENOCARCINOMA; BIOSYNTHESIS; COLORECTAL TUMOR; METABOLISM; MICROARRAY ANALYSIS; MIDDLE AGED; PATHOLOGY; STROMA CELL;

ADENOCARCINOMA; AGED; CARRIER PROTEINS; COLORECTAL NEOPLASMS; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICROARRAY ANALYSIS; MICROFILAMENT PROTEINS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; STROMAL CELLS; SYNDECAN-1; TUMOR MARKERS, BIOLOGICAL;

EID: 47549100061     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-185     Document Type: Article

References (38)

1. Bernfield M Kokenyesi R Kato M Hinkes MT Spring J Gallo RL Lose EJ Biology of the syndecans: A family of transmembrane heparan sulfate proteoglycans Annu Rev Cell Biol 1992, 8:365-393. 1335744 10.1146/ annurev.cb.08.110192.002053
2. Alexopoulou AN Multhaupt HA Couchman JR Syndecans in wound healing, inflammation and vascular biology Int J Biochem Cell Biol 2007, 39:505-528. 17097330 10.1016/j.biocel.2006.10.014
3. Chakravarti R Adams JC Comparative genomics of the syndecans defines an ancestral genomic context associated with matrilins in vertebrates BMC Genomics 2006, 7:83. 16620374 10.1186/1471-2164-7-83 1464127
4. Sanderson RD Yang Y Syndecan-1: A dynamic regulator of the myeloma microenvironment Clin Exp Metastasis 2007, 25:149-159. 18027090 10.1007/ s10585-007-9125-3
5. Liu BY Kim YC Leatherberry V Cowin P Alexander CM Mammary gland development requires syndecan-1 to create a beta-catenin/TCF-responsive mammary epithelial subpopulation Oncogene 2003, 22:9243-9253. 14681683 10.1038/sj.onc.1207217
6. McDermott SP Ranheim EA Leatherberry VS Khwaja SS Klos KS Alexander CM Juvenile syndecan-1 null mice are protected from carcinogen-induced tumor development Oncogene 2007, 26:1407-1416. 16953225 10.1038/ sj.onc.1209930
7. Xu J Park PW Kheradmand F Corry DB Endogenous attenuation of allergic lung inflammation by syndecan-1 J Immunol 2005, 174(9):5758-5765. 15843578
8. Stepp MA Gibson HE Gala PH Iglesia DD Pajoohesh-Ganji A Pal-Ghosh S Brown M Aquino C Schwartz AM Goldberger O Hinkes MT Bernfield M Defects in keratinocyte activation during wound healing in the syndecan-1-deficient mouse J Cell Sci 2002, 115:4517-4531. 12414997 10.1242/jcs.00128
9. Stepp MA Liu Y Pal-Ghosh S Jurjus RA Tadvalkar G Sekaran A Losicco K Jiang L Larsen M Li L Yuspa SH Reduced migration, altered matrix and enhanced TGFbeta1 signaling are signatures of mouse keratinocytes lacking Sdc1 J Cell Sci 2007, 120:2851-2863. 17666434 10.1242/jcs.03480
10. Leppä S Härkönen P Jalkanen M Steroid-induced epithelial-fibroblastic conversion associated with syndecan suppression in S115 mouse mammary tumor cells Cell Regul 1991, 2(1):1-11. 361707 2007184
11. Leppä S Mali M Miettinen HM Jalkanen M Syndecan expression regulates cell morphology and growth of mouse mammary epithelial tumor cells Proc Natl Acad Sci USA 1992, 89:932-936. 1736308 10.1073/ pnas.89.3.932 48359
12. Leppä S Vleminckx K Van Roy F Jalkanen M Syndecan-1 expression in mammary epithelial tumor cells is E-cadherin-dependent J Cell Sci 1996, 109(Pt 6):1393-1403. 8799827
13. Liebersbach BF Sanderson RD Expression of syndecan-1 inhibits cell invasion into type I collagen J Biol Chem 1994, 269(31):20009-20013. 8051085
14. Levy P Munier A Baron-Delage S Di Gioia Y Gespach C Capeau J Cherqui G Syndecan-1 alterations during the tumorigenic progression of human colonic Caco-2 cells induced by human Ha-ras or polyoma middle T oncogenes Br J Cancer 1996, 74:423-431. 8695359
15. Wiksten JP Lundin J Nordling S Kokkola A Haglund C A prognostic value of syndecan-1 in gastric cancer Anticancer Res 2000, 20:4905-4907. 11326638.
16. Wiksten JP Lundin J Nordling S Lundin M Kokkola A von Boguslawski K Haglund C Epithelial and stromal syndecan-1 expression as predictor of outcome in patients with gastric cancer Int J Cancer 2001, 95(1):1-6. 10.1002/1097-0215(20010120)95:1<1::AID-IJC1000>3.0.CO;2-5 11241302
17. Inki P Joensuu H Grénman R Klemi P Jalkanen M Association between syndecan-1 expression and clinical outcome in squamous cell carcinoma of the head and neck Br J Cancer 1994, 70(2):319-323. 8054282
18. Hasengaowa Kodama J Kusumoto T Shinyo Y Seki N Hiramatsu Y Prognostic significance of syndecan-1 expression in human endometrial cancer Ann Oncol 2005, 16:1109-1115. 15851381 10.1093/annonc/mdi224
19. Shinyo Y Kodama J Hasengaowa Kusumoto T Hiramatsu Y Loss of cell-surface heparan sulfate expression in both cervical intraepithelial neoplasm and invasive cervical cancer Gynecol Oncol 2005, 96:776-783. 15810155 10.1016/j.ygyno.2004.11.004
20. Máthé M Suba Z Németh Z Tátrai P Füle T Borgulya G Barabás J Kovalszky I Stromal syndecan-1 expression is an adverseprognostic factor in oral carcinomas Oral Oncol 2006, 42:493-500. 16364677 10.1016/j.oraloncology.2005.10.003
21. Conejo JR Kleeff J Koliopanos A Matsuda K Zhu ZW Goecke H Bicheng N Zimmermann A Korc M Friess H Büchler MW Syndecan-1 expression is up-regulated in pancreatic but not in other gastrointestinal cancers Int J Cancer 2000, 88:12-20. 10962434 10.1002/ 1097-0215(20001001)88:1<12::AID-IJC3>3.0.CO;2-T
22. Leivonen M Lundin J Nordling S von Boguslawski K Haglund C Prognostic value of syndecan-1 expression in breast cancer Oncology 2004, 67:11-28. 15459490 10.1159/000080280
23. Tsanou E Ioachim E Briasoulis E Charchanti A Damala K Karavasilis V Pavlidis N Agnantis NJ Clinicopathological study of the expression of syndecan-1 in invasive breast carcinomas, correlation with extracellular matrix components J Exp Clin Cancer Res 2004, 23(4):641-650. 15743035
24. Götte M Kersting C Ruggiero M Tio J Tulusan AH Kiesel L Wülfing P Predictive value of syndecan-1 expression for the response to neoadjuvant chemotherapy of primary breast cancer Anticancer Res 2006, 26(1B):621-627. 16739330
25. Surveillance, Epidemiology and End Results http://seer.cancer.gov/
26. Hashimoto Y Skacel M Lavery IC Mukherjee AL Casey G Adams JC Prognostic significance of fascin expression in advancedcolorectal cancer: An immunohistochemical study of colorectal adenomas and adenocarcinomas BMC Cancer 2006, 6:241. 17029629 10.1186/1471-2407-6-241 1615879
27. Puppa G Maisonneuve P Sonzogni A Masullo M Chiappa A Valerio M Zampino MG Franceschetti I Capelli P Chilosi M Menestrina F Viale G Pelosi G Independent prognostic value of fascin immunoreactivity in stage III-IV colonic adenocarcinoma Br J Cancer 2007, 96:1118-1126. 17375048 10.1038/ sj.bjc.6603690
28. Adams JC Kureishy N Taylor AL A role for syndecan-1 in coupling fascin spike formation by thrombospondin-1 J Cell Biol 2001, 152:1169-1182. 11257118 10.1083/jcb.152.6.1169 2199199
29. Day RM Hao X Ilyas M Daszak P Talbot IC Forbes A Changes in the expression of syndecan-1 in the colorectal adenoma-carcinoma sequence Virchows Arch 1999, 434:121-125. 10071246 10.1007/s004280050315
30. Fujiya M Watari J Ashida T Honda M Tanabe H Fujiki T Saitoh Y Kohgo Y Reduced expression of syndecan-1 affects metastatic potential and clinical outcome in patients with colorectal cancer Jpn J Cancer Res 2001, 92:1074-1081. 11676858
31. Lundin M Nordling S Lundin J Isola J Wiksten JP Haglund C Epithelial syndecan-1 expression is associated with stage andgrade in colorectal cancer Oncology 2005, 68:306-313. 16020957 10.1159/000086969
32. Mennerich D Vogel A Klaman I Dahl E Lichtner RB Rosenthal A Pohlenz HD Thierauch KH Sommer A Shift of syndecan-1 expression from epithelial to stromal cells during progression of solid tumours Eur J Cancer 2004, 40:1373-1382. 15177497 10.1016/j.ejca.2004.01.038
33. Sobin LH Wittekind Ch editors TNMClassification of Malignant Tumours New York: John Wiley & Sons, Inc Sixth 2000
34. Lindblom A Different mechanisms in the tumorigenesis of proximal and distal colon cancers Curr Opin Oncol 2001, 13:63-69. 11148689 10.1097/ 00001622-200101000-00013
35. Tlsty TD Coussens LM Tumor stroma and regulation of cancer development Annu Rev Pathol 2006, 1:119-150. 18039110 10.1146/ annurev.pathol.1.110304.100224
36. Chakravarti R Sapountzi V Adams JC Functional role of syndecan-1 cytoplasmic V region in lamellipodial spreading, actinbundling, and cell migration Mol Biol Cell 2005, 16:3678-3691. 15930135 10.1091/ mbc.E04-10-0907 1182307
37. Vignejevic D Schoumacher M Gavert N Janssen K-P Jih G lae M Louvard D Ben-Ze-ev A Robine S Fascin, a novel target of β-catenin-TCF signaling, is expressed at the invasive front of human colon cancer Can Res 2007, 67:6844-6853. 10.1158/0008-5472.CAN-07-0929
38. Chilosi M Zamò A Doglioni C Reghellin D Lestani M Montagna L Pedron S Ennas MG Cancellieri A Murer B Poletti V Migratory marker expression in fibroblast foci of idiopathic pulmonary fibrosis Respir Res 2006, 7:95. 16813649 10.1186/1465-9921-7-95 1538593